PRAME and neoplasm: PRAME (preferentially expressed antigen in melanoma) is a cancer testis antigen (CTA) that was first identified in 1997 through analysis of the specificity of tumor-reactive T-cell clones derived from a patient with metastatic cutaneous melanoma [13].